Transcriptomics

Dataset Information

0

TET2 promotes anti-tumor immunity by governing G-MDSCs and CD8+ T cell numbers


ABSTRACT: Host immune response is a fundamental mechanism for attenuating cancer progression. Here we report a pivotal role of the DNA demethylase and tumor suppressor TET2 played in host antitumor immunity. Deletion of Tet2 dramatically elevated the IL-6 level in Tet2-/- mice upon tumor challenge. The elevated IL-6 greatly stimulated the immunosuppressive granulocytic myeloid-derived suppressor cells (G-MDSCs), which in turn significantly reduced CD8+ T cells upon tumor challenge. Consequently, systematic knockout of the Tet2 in mice led to accelerated syngeneic tumor growth, which was constrained by anti-PD-1 blockade. Removal of G-MDSCs by the anti-mouse Ly6g Ab restored the numbers of CD8+ T cells in Tet2-/- mice and rebooted their anti-tumor activity. Importantly, anti-IL-6 Ab treatment blocked the expansion of G-MDSCs and inhibited syngeneic tumor growth. Collectively, these findings reveal a TET2-mediated IL-6/G-MDSC/CD8+ T immune response cascade that safeguards host adaptive anti-tumor immunity, offering a cell non-autonomous mechanism of TET2 for tumor suppression.

ORGANISM(S): Mus musculus

PROVIDER: GSE144787 | GEO | 2020/08/04

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2010-06-16 | E-GEOD-21927 | biostudies-arrayexpress
2020-09-01 | E-MTAB-9316 | biostudies-arrayexpress
2013-11-18 | E-GEOD-50128 | biostudies-arrayexpress
2011-04-13 | E-GEOD-28545 | biostudies-arrayexpress
2022-04-20 | GSE199113 | GEO
2010-06-03 | GSE21927 | GEO
| PRJNA604913 | ENA
2013-11-18 | GSE50128 | GEO
2022-07-01 | GSE134191 | GEO
2022-06-13 | E-MTAB-11773 | biostudies-arrayexpress